Skip to main content

March 18, 2020 - Update on ATN Funding and Activities in Response to COVID-19

This article will be kept updated as more information is available.

Activities

2020 Spring ATN Virtual Meeting - Updated March 13, 2020

With the priority to keep our ATN family safe, the ATN leadership have decided to cancel the in-person ATN Meeting scheduled for April 14-17, 2020. Instead, we will be holding a virtual meeting, so please continue to reserve those days. Stay tuned for additional details regarding the revised agenda and connection information. Thank you for your understanding.

Updated April 7, 2020: Click here for the Spring full meeting event page, which includes an agenda and a video message about the virtual format. 

 

Funding-related Updates

ATN Request for Proposals (RFP): Research Aimed at Ending the HIV Epidemic: A Plan for America (Updated March 16, 2020)

When delays occur because the applicant and/or their local partners are officially closed or unable to secure partnership memoranda of understanding/agreements due to the effects of COVID-19, the NIH ATN leadership will consider acceptance of late applications on a case-by-case basis. Applicants need not request advance permission to submit late due to this declared emergency. However, an e-mail, if possible, by March 23, 2020, notifying us of the late submission to ATNadmin@unc.edu would be appreciated.

More about the ATN RFP: https://atnweb.org/atnweb/ending-the-hiv-epidemic-request-for-proposals

General Funding Announcements 

March 16, 2020: Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-087.html

March 10, 2020: General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-083.html

 

Guidance from The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC)

"COVID-19: What people with HIV should know" on the CDC website 

"Interim Guidance related to COVID-19 and Persons with HIV" Letter from the NIH Office of AIDS Research director, Dr. Maureen Goodenow